Advertisement

Lymphoma Cancer | Tumor

CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.

Hank Green Diagnosed With Lymphoma, Jeff Bridges and Martina Navratilova Provide Cancer Updates and More

May 26th 2023

From YouTuber Hank Green announcing his lymphoma diagnosis, to Jeff Bridges, Martina Navratilova and Leanne Hainsby giving updates on their cancer, here’s what’s happening in the oncology space this week.

Lymphoma Survivor Knows that Patients Can Be Their Own Best Advocates

May 24th 2023

“Nobody’s going to fight for your life the way you’re going to fight for your life,” Hodgkin’s lymphoma survivor, Paula Ngon, told CURE®.

FDA Approves Epkinly for Relapsed/Refractory DLBCL

May 19th 2023

The FDA approval of Epkinly also includes a subset of patients with indolent lymphoma-related DLBCL and those with high-grade B-cell lymphoma after two or more systemic therapies.

Frozen Stem Cell Grafts Linked to Higher Relapse Rates in Blood Cancer

May 18th 2023

Cryopreserved stem cells led to a higher rate of relapse in patients with blood cancer, though there was no difference in survival, research showed.

‘Pokémon’ Cast Member to Retire for Cancer Treatment, Musicians Die of Cancer and More

April 21st 2023

From ‘Pokémon’ actor James Carter Cathcart stepping away from the show to undergo cancer treatment to Ahmad Jamal and Otis Redding III dying of cancer, here’s what’s happening in the oncology space this week.

Celebrate Small Victories With Cancer

April 20th 2023

Cancer-related can be consuming, so my sister and I make sure to celebrate the little victories along the way.

FDA Approves Polivy Regimen for DLBCL

April 19th 2023

The Food and Drug Administration approved Polivy plus Rituxan, cyclophosphamide, doxorubicin and prednisone for patients with previously untreated diffuse large B-cell lymphoma — marking the first new regimen in nearly two decades for this patient population.

Access to Therapies Through Clinical Trials ‘a Blessing’ for Lymphoma, Other Cancers

April 18th 2023

One patient was able to access a therapy for follicular lymphoma before it was approved by the FDA, which allowed him to help future patients through his experience.

FDA Approves Omisirge to Reduce Infection Risk in Patients With Blood Cancer

April 17th 2023

Omisirge is an umbilical cord blood-based therapy that may prevent infection in patients with blood cancer undergoing stem cell transplant.

Self-Advocacy in Cancer Care Is Vital, Though Often Uncomfortable

April 5th 2023

I learned that self-advocacy is not about proving an oncology wrong or deciding that one drug is better than the other. It’s about speaking up for what you think is right.

My Mastectomy Results Were Not What I Expected

March 23rd 2023

Choosing to get a mastectomy was a difficult decision to make, but then the pathology results came back indicating a second cancer.

Difficult Conversations and Realizations of Cancer

March 14th 2023

Cancer-related decisions put strain on relationships between myself and family members.

Autoinjector Version of Udenyca FDA Approved to Reduce Infection Risk After Myelosuppressive Chemo

March 6th 2023

This updated administration of Udenyca allows patients to receive this treatment in the office or at home.

Healthy Diet May Improve Side Effects for Lymphoma Survivors

February 27th 2023

Cancer survivors who are experiencing side effects from treatment, such as chronic fatigue, may benefit from a healthier diet.

Chris Tucker Urges Black Men to Know Cancer Risk, Peloton Instructor Sees Mindset as a ‘Superpower’ During Cancer Treatment and More

February 24th 2023

From comedian Chris Tucker teaming up with a nonprofit to educate Black men on their prostate cancer risk to Leeane Hainby and Rep. Jamie Raskin providing updates on their cancer treatment, here’s what’s happening in the cancer space this week.

One Survivor Helps Others Find Their ‘Cancer Love Story’

February 21st 2023

After receiving supportive care during her college cancer journey, this survivor now works to guide other patients through their treatments.

Anthracyclines May Increase Heart Failure in Patients with Breast Cancer, Lymphoma

February 20th 2023

Patients with cancer should keep a healthy heart during cancer treatment by exercising regularly and eating healthy, an expert emphasized.

Here We Go Again: Waiting for Results After Another Cancer Scare

February 15th 2023

I was optimistic about my lymphoma diagnosis and new treatment plan when a lump was found after I underwent a mammogram.

Cancer Made Me Superstitious

January 31st 2023

After being diagnosed with cancer, I’m nervous to plan for my future, and can’t say I’m in remission without knocking on wood.

Wondering ‘Why Me’ After a Cancer Diagnosis

January 23rd 2023

I exercised and ate healthy, yet still received a cancer diagnosis, leaving me wondering, “why me?”

Tennis Player Chris Everet Is Cancer-Free, Duran Duran Guitarist Discusses His Disease and More

January 20th 2023

From Tennis star Chris Evert’s cancer-free status to Duran Duran’s Andy Taylor talking about his prostate cancer, here’s what’s happening in the oncology space this week.

‘Getting Close’ To Making Stem, Bone Marrow Transplants Safer for Patients With Blood Cancer

January 16th 2023

Patients with blood cancer may develop serious infections after transplants, but a T-cell therapy may improve symptoms and side effects.

Top FDA Approvals of 2022

December 27th 2022

There were some monumental FDA approvals in the cancer space during 2022 — here’s a roundup of our most-read agency decisions of the year.

Novel Drug May Provide New Treatment Option for Pretreated Relapsed-Refractory Lymphoma

December 26th 2022

Data demonstrate that iberdomide alone or in combination with other treatments may be a promising option for patients with relapsed/refractory lymphoma.

FDA Approves Lunsumio to Treat Relapsed/Refractory Follicular Lymphoma

December 23rd 2022

Patients with relapsed/refractory follicular lymphoma — a group that traditionally has limited treatment options — now have a new bispecific antibody available.

Triathlons Helped Three-Time Cancer Survivor 'Love Every Single Day' of His Life

December 8th 2022

Robert Atteberry never gave up, even after three cancer diagnoses, and has found a motivation and passion for competing in triathlons during survivorship.

5 Things I Learned Going From Patient to Cancer Caregiver

December 7th 2022

Years after I went through mesothelioma, my husband was diagnosed with cancer, causing a reversal in the patient-caregiver roles.

FDA to Expedite Review of Novel Non-Hodgkin Lymphoma Drug

November 23rd 2022

The Food and Drug Administration granted a priority review to epcoritamab for certain patients with large B-cell lymphoma, an aggressive type of blood cancer.

FDA Approves Adcetris Plus Chemotherapy for Children With High-Risk Hodgkin Lymphoma

November 10th 2022

The Food and Drug Administration approved Adcetris plus chemotherapy for pediatric patients with classical high-risk Hodgkin lymphoma.

Clinical Trial Kicks Off Evaluating a New Drug for a Group of Solid Cancers

November 4th 2022

A novel drug, MRT-2359, will be studied in a phase 1/2 trial for patients with MYC-driven cancers.

NEXT PAGE
PREVIOUS PAGE
Advertisement
Advertisement